Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation

Abstract Aims To investigate the exact prevalence of glucose metabolism disorders, and their impact on left atrial (LA) remodelling and reversibility in patients with atrial fibrillation (AF). Methods and results We examined 204 consecutive patients with AF who underwent their first catheter ablation (CA). Oral glucose tolerance test was used to evaluate glucose metabolism disorders in 157 patients without known diabetes mellitus (DM). Echocardiography was performed before and 6 months after CA. Oral glucose tolerance test identified abnormal glucose metabolism in 86 patients [11 with newly diagnosed DM, 74 with impaired glucose tolerance (IGT) and 1 with impaired fasting glucose (IFG)]. Ultimately, 65.2% of patients had abnormal glucose metabolism. Diabetes mellitus group had the worst LA reservoir strain and LA stiffness (both P < 0.05), while there was no significant difference in baseline LA parameters between normal glucose tolerance (NGT) group and IGT/IFG group. The prevalence of LA reverse remodelling (≥15% decrease in the LA volume index at 6 months after CA) was significantly higher in NGT group compared with IGT/IFG and DM group (64.1 vs. 38.6 vs. 41.5%, P = 0.006). Both DM and IFG/IGT carry a significant risk of lack of LA reverse remodelling independent of baseline LA size and AF recurrence. Conclusion Approximately 65% of patients with AF who underwent their first CA had abnormal glucose metabolism. Patients with DM had significantly impaired LA function compared with non-DM patients. Impaired glucose tolerance/IFG as well as DM carries significant risk of unfavourable LA reverse remodelling. Our observations may provide valuable information regarding the mechanisms and therapeutic strategies of glucose metabolism-related AF.

[1]  H. Crijns,et al.  Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation: data from the RACE V study. , 2023, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2]  M. Kavousi,et al.  Autoimmune diseases and new-onset atrial fibrillation: a UK Biobank study , 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  H. Heidbuchel,et al.  The challenge of managing multimorbid atrial fibrillation: a pan-European European Heart Rhythm Association (EHRA) member survey of current management practices and clinical priorities , 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  L. Friberg,et al.  Impaired fasting glucose: a risk factor for atrial fibrillation and heart failure , 2021, Cardiovascular Diabetology.

[5]  T. Biering-Sørensen,et al.  Left atrial strain predicts incident atrial fibrillation in the general population: the Copenhagen City Heart Study. , 2021, European heart journal. Cardiovascular Imaging.

[6]  G. Boriani,et al.  Medical therapies for prevention of cardiovascular and renal events in patients with atrial fibrillation and diabetes mellitus. , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  I. Komuro,et al.  Correlation Between the Cohorts for Heart and Aging Research in Genomic Epidemiology-Atrial Fibrillation Risk Score and Left Atrial Remodeling in the General Population. , 2021, Circulation. Arrhythmia and electrophysiology.

[8]  G. Breithardt,et al.  Prognostic markers of all-cause mortality in patients with atrial fibrillation: data from the prospective long-term registry of the German Atrial Fibrillation NETwork (AFNET). , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[9]  A. Banerjee,et al.  Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study , 2021, The lancet. Diabetes & endocrinology.

[10]  G. Pedrizzetti,et al.  Evaluation of Left Atrial Size and Function: Relevance for Clinical Practice. , 2020, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[11]  R. Ritchie,et al.  Basic Mechanisms of Diabetic Heart Disease. , 2020, Circulation research.

[12]  E. Urbina,et al.  Left atrial strain and diastolic function abnormalities in obese and type 2 diabetic adolescents and young adults , 2020, Cardiovascular Diabetology.

[13]  T. Marwick,et al.  Use of echocardiography to stratify the risk of atrial fibrillation: comparison of left atrial and ventricular strain. , 2019, European heart journal cardiovascular Imaging.

[14]  Y. Sakata,et al.  Left Atrial Reverse Remodeling After Catheter Ablation of Nonparoxysmal Atrial Fibrillation in Patients With Heart Failure With Reduced Ejection Fraction. , 2018, The American journal of cardiology.

[15]  Ming Ann Sim,et al.  Wider perioperative glycemic fluctuations increase risk of postoperative atrial fibrillation and ICU length of stay , 2018, PloS one.

[16]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association , 2018, Circulation.

[17]  J. De Sutter,et al.  Echocardiographic reference ranges for normal left atrial function parameters: results from the EACVI NORRE study , 2018, European heart journal cardiovascular Imaging.

[18]  R. Sacco,et al.  Association of chronic kidney disease with impaired left atrial reservoir function: A community-based cohort study , 2017, European journal of preventive cardiology.

[19]  K. Shimada,et al.  Pre-Procedural Serum Atrial Natriuretic Peptide Levels Predict Left Atrial Reverse Remodeling After Catheter Ablation in Patients With Atrial Fibrillation. , 2016, JACC. Clinical electrophysiology.

[20]  W. Haverkamp,et al.  Normal values and clinical relevance of left atrial myocardial function analysed by speckle-tracking echocardiography: multicentre study. , 2015, European heart journal cardiovascular Imaging.

[21]  R. Mahajan,et al.  Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. , 2014, Journal of the American College of Cardiology.

[22]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[23]  C. Cuspidi,et al.  The association between heart rate variability and biatrial phasic function in arterial hypertension. , 2014, Journal of the American Society of Hypertension : JASH.

[24]  R. Califf,et al.  Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial. , 2013, American heart journal.

[25]  P. Wierup,et al.  Left Atrial Reverse Remodeling Following Valve Surgery for Chronic Degenerative Mitral Regurgitation in Patients with Preoperative Sinus Rhythm: Effects on Long‐Term Outcome , 2013, Journal of cardiac surgery.

[26]  J. Pankow,et al.  Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study , 2011, Heart.

[27]  M. Cameli,et al.  Early detection of left atrial strain abnormalities by speckle-tracking in hypertensive and diabetic patients with normal left atrial size. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[28]  K. Filion,et al.  Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. , 2011, The American journal of cardiology.

[29]  Jeroen J. Bax,et al.  Left atrial strain predicts reverse remodeling after catheter ablation for atrial fibrillation. , 2011, Journal of the American College of Cardiology.

[30]  A. Tveit,et al.  Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects , 2008, Cardiovascular diabetology.

[31]  J. Seward,et al.  Left atrial reservoir function as a potent marker for first atrial fibrillation or flutter in persons > or = 65 years of age. , 2008, The American journal of cardiology.

[32]  J. Stein,et al.  Left Atrial Volume Is Associated with Inflammation and Atherosclerosis in Patients with Kidney Disease , 2007, Echocardiography.

[33]  B. Popescu,et al.  Left atrial remodelling early after mitral valve repair for degenerative mitral regurgitation , 2007, Heart.

[34]  J. Seward,et al.  Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort. , 2007, European heart journal.

[35]  B. Zinman,et al.  Impaired Fasting Glucose and Impaired Glucose Tolerance , 2007, Diabetes Care.

[36]  N. Secher,et al.  [Patients with kidney disease]. , 2006, Ugeskrift for laeger.

[37]  James B Seward,et al.  Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? , 2006, Journal of the American College of Cardiology.

[38]  H. Wellens,et al.  Successful Radiofrequency Ablation in Patients With Previous Atrial Fibrillation Results in a Significant Decrease in Left Atrial Size , 2005, Circulation.

[39]  C. Viscoli,et al.  Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke. , 2005, Archives of internal medicine.

[40]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[41]  A. Hamsten,et al.  Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study , 2002, The Lancet.

[42]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[43]  OUP accepted manuscript , 2022, Europace.

[44]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[45]  Hugh Calkins,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2014, Journal of the American College of Cardiology.

[46]  J. Leahy.  Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care , 2008 .